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Summary: The spectrophotometric method for the de-
termination of angiotensin-converting enzyme in serum using
/7-hydroxyhippuryl-L-histidyl-L-leucine äs Substrate is com-
mercially available äs a test kit. It shows excellent linearity over
the whole ränge of catalytic concentration found in serum. We
describe several modifications of this method to simplify and
economize the procedure.
Vereinfachung eines kommerziell erhältlichen Tests für Angioten-?
sin Con verfing Enzyme im Serum
Zusammenfassung: Die spektrophotometrische Methode für
die Bestimmung von Angiotensin Convefting Enzyme mit p-
Hydroxyhippuryl-L-histidyl-L-leucin ist als Testbesteck im
Handel. Sie zeigt eine hervorragende Linearität über den gesam-
ten Bereich der in Serum beobachteten katalytischen Konzen-
tration. Wir beschreiben hier mehrere Modifikationen dieser
Methode, die das Verfahren vereinfachen und ökonomischer
gestalten.
Introduction
In humans, angiotensin-converting enzymejs found in several
tissue extracts arid fluids.
Angiotensin-converting enzyme is found to be elevated in serum
in certain diseases: i. e.: Gaucher's disease, hyperthyroidism and
sarcoidosis (1). Furthermore sequential measurements of the
enzyme in serum are of great help in monitoring the activity
of sarcoidosis (1).
Methods have been described for the quantitative determina-
tion of the enzyme using the synthetic Substrate, hippuryi-L-
histidyl-L-leucine (2, 3). However, these methods are complica-
ted and time-consuming. Recently, Kasahara & Ashihara (4)
introduced a simple and rapid spectrophotometric method
using /7-hydroxyhippuryl-L-histidyl-L-leucine äs a Substrate.
This new method, commercialiy available äs a test kit, shows
excellent linearity over the whole ränge of enzymatic activities
found in serum, and a good correlation was found with the
spectrophotometric method using hippuryl-L-histidyl-L-leucine
(5). In the present communication several modifications of
this method are described, which simplify and economize the
procedure.
Materials and Methods
All results obtained with the method under investigation (4)
are compared with the results of the fluorimetric assay using
hippuryl-L-histidyl-L^leucine (3). The latter method was perfor-
med essentially äs described, with the exception that a borate
buffer was used instead of a phosphate buffer (6).
The commercialiy available angiotensin-converting enzyme as-
say, based on a colorimetric method äs described by Kasahara &
Ashihara (4), was performed according to a modified procedure
äs described by Boomsma & Schalekamp (5). Briefly: to 100 ul
of sample serum, 500 of Substrate solution (10 mmol/1 /?-
hydroxyhippuryl-L-histidyl-L-leucine; 2.5 mmol/14-amino-anti-
pyrine; 3 kU/1 hippuricase in borate buffer) were added. After
iricubatipn of this mixture at 37 °C for 30 minutes, 1.5 ml of
reaction Stopper and developer solution (3 mmol/1 EDTA; 6.5
mmol/1 NaIO4; 2 g/l Triton X-100) were added and mixed.
Incubation was continued for a further 3 minutes at 37 °C.
Serum blänks were prepared by rnixing 100 serum with 50
EDTA (40 mmol/1) before addition of the Substrate solution.
The final concentration of EDTA is sufflcient for complete
Inhibition of the catalytic activity (4).
By pipetting the amounts of serum and reagents äs recommen-
ded by the manufacturer, one packaged assay kit serves for the
assay of 20 samples.
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We have modified this procedure in such a way that 100 instead
of 20 samples can be assayed. Using the above-mentioned
procedure the quantity of sample serum is reduced from 100
μΐ lo 20 μΐ. Το keep Ihe protocol unaltered the quantities of
the successive reagents are also reduced by the same factor.
The final reaction volume becomes 420 μΐ. After the last incuba-
tion stept 250 μΐ of the 420 μΐ is pipetted into the wells of a
microtiter plate and absorbance is measured in a Titertek®
Multiskan photometer (Flow Laboratories, Ltd Scotland) at
492 nm.
The catalytic concentration was calcuiated according to the
formula.
Asampie - Ablank 0.42 l
12000 0.02 30
χ ΙΟ6 χ l .45 [μηιοΐ/min · 1], [U/l]
The factor 1.45 has been introduced to correct for the measure-
ment at a wavelength of 492 nm instead of 505 nm and for the
shorter optical path length of the sample in the microtiter plate.
As recommended by the manufacturer, the reconstituted sub-
strate should be used within a day and the reconstituted Stopper
and developer substance within 7 days when stored at 4 °C. To
test the stability of the reagents after reconstitution when stored
at — 70 °C, aliquots of the regents were frozen in polystyrene
tubes immediately after reconstitution. After one to eight weeks
reagents were thawed and used in the test.
Results and Discussion
Results obtained with the modified method by using small
volumes and microtiter plates and the method of Friedland &
Silverstein (3) were compared. With 44 different sera a very good
correlation between the fluorimetric method (x) and the present
method (y) was found (flg. 1). The linear regression equati n
calcuiated was y = 0.34 χ 4- 0.54 with r = 0.981. Two sera
were used to determine the interassay Variation s well s the
intra-assay Variation. As shown in table l, small coefficients of
Variation were found. Moreover performing the test in duplicate
did not increase precision. It was observed that storage of
reconstituted reagents at — 70 °C for a period up to 8 weeks
did not result in any observable loss of reactivity. Test results
obtained by using reconstituted and stored reagents were
identical with those obtained with freshly reconstituted reagents.
Reagents that are not used within a day can therefore be stored
at -70 °C and used later.
From the results it is clear that the angiotensin^converting
enzyme activity can be accurately measured with the proposed
modifications of the test kit. With these modifications the
method is partly automated and becomes more economical,
permitting a 5-fold increase in the number of possible assays.
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Fig. 1. Relation between the fluorimetric rnethod (substrate:
hippuryl-L-histidyl-L-leucine) and the colorimetric test
kit modified s described (substrate:/7-hydroxyhippuryl-
L^histidyl-L-le cine). The linear regression equati n
was y = 0.34x + 0.54 with a correlation coefficient of
0.981.
The catalytic concentration of angiotensiii-converting
enzyme was measured in 44 sera.
Tab. l. Interassay Variation and intra-assay Variation of the
modified method for angiotensin-converting enzyme
catalytic cpncentration.
Interassay
(singular)
Interassay
(duplicate)
Iiitra-assay
(singular)
Se-
rum
A
B
A
B
C
N
17
17
18
18
14
Catalytic
concentration
χ SD
(U/l) (U/l)
19.0 1.3
14.7 0.9
18.8 1.3
14.6 1.0
19.8 0.9
CV
(%)
6.9
6.1
6.9
6.5
4.6
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